These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3510983)

  • 1. Environmental modulation of lipopolysaccharide chain length alters the sensitivity of Escherichia coli to the neutrophil bactericidal/permeability-increasing protein.
    Weiss J; Hutzler M; Kao L
    Infect Immun; 1986 Feb; 51(2):594-9. PubMed ID: 3510983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria.
    Weiss J; Victor M; Elsbach P
    J Clin Invest; 1983 Mar; 71(3):540-9. PubMed ID: 6338040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OmpR-dependent and OmpR-independent responses of Escherichia coli to sublethal attack by the neutrophil bactericidal/permeability increasing protein.
    Prohinar P; Forst SA; Reed D; Mandic-Mulec I; Weiss J
    Mol Microbiol; 2002 Mar; 43(6):1493-504. PubMed ID: 11952900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J; Muello K; Victor M; Elsbach P
    J Immunol; 1984 Jun; 132(6):3109-15. PubMed ID: 6373924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
    Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.
    Mannion BA; Weiss J; Elsbach P
    J Clin Invest; 1990 Mar; 85(3):853-60. PubMed ID: 2179269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of K1-encapsulated Escherichia coli to killing by the bactericidal/permeability-increasing protein of rabbit and human neutrophils.
    Weiss J; Victor M; Cross AS; Elsbach P
    Infect Immun; 1982 Dec; 38(3):1149-53. PubMed ID: 6759406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE; Weiss J; Doerfler ME; Elsbach P
    J Exp Med; 1991 Sep; 174(3):649-55. PubMed ID: 1875165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
    Levy O; Martin S; Eichenwald E; Ganz T; Valore E; Carroll SF; Lee K; Goldmann D; Thorne GM
    Pediatrics; 1999 Dec; 104(6):1327-33. PubMed ID: 10585984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J
    J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN; Wilde CG; Collins MS; Snable JL; Thornton MB; Scott RW
    J Immunol; 1992 Jan; 148(2):532-7. PubMed ID: 1729370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin.
    Katz SS; Chen K; Chen S; Doerfler ME; Elsbach P; Weiss J
    Infect Immun; 1996 Sep; 64(9):3592-600. PubMed ID: 8751904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure.
    Weiss J; Beckerdite-Quagliata S; Elsbach P
    J Clin Invest; 1980 Mar; 65(3):619-28. PubMed ID: 6986410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification.
    Mannion BA; Kalatzis ES; Weiss J; Elsbach P
    J Immunol; 1989 Apr; 142(8):2807-12. PubMed ID: 2539411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The region around residue 115 of human bactericidal/permeability-increasing protein is not involved in lipopolysaccharide binding or bactericidal activity. Chemical synthesis and expression of a gene coding for the active domain and characterization of recombinant proteins.
    Qi SY; Li Y; O'Connor CD
    Biochem J; 1994 Mar; 298 Pt 3(Pt 3):711-8. PubMed ID: 8141787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis.
    Calvano SE; Thompson WA; Marra MN; Coyle SM; de Riesthal HF; Trousdale RK; Barie PS; Scott RW; Moldawer LL; Lowry SF
    Arch Surg; 1994 Feb; 129(2):220-6. PubMed ID: 7508221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.
    Gazzano-Santoro H; Parent JB; Grinna L; Horwitz A; Parsons T; Theofan G; Elsbach P; Weiss J; Conlon PJ
    Infect Immun; 1992 Nov; 60(11):4754-61. PubMed ID: 1398985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins.
    Marra MN; Thornton MB; Snable JL; Leong S; Lane J; Wilde CG; Scott RW
    Blood Purif; 1993; 11(2):134-40. PubMed ID: 7506040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains.
    Iovine NM; Elsbach P; Weiss J
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10973-8. PubMed ID: 9380744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.